Intravascular cell therapy in stroke: predicting the future trends.

Area of Science:

• Neuroscience
• Regenerative Medicine
• Translational Research

Background:

• Preclinical stroke research heavily influences early-phase clinical studies.
• Understanding trends in cell delivery and product selection is crucial for translational success.

Purpose of the Study:

• To review trends in delivery routes and cell products for preclinical stroke research over the last two decades.
• To identify potential strategies for improving cell therapy translation into clinical studies.

Main Methods:

• Retrospective analysis of preclinical stroke research data.
• Examination of cell delivery routes and cell product choices.

Main Results:

• Intravenous delivery of mesenchymal stem cells is the predominant method in experimental stroke research.
• This approach also dominates early-phase clinical studies for stroke.

Conclusions:

• Current practices in cell therapy for stroke show a consistent preference for intravenous mesenchymal stem cells.
• Discussing advantages and risks may enhance translational success and accelerate clinical development of safe cell products.